We narrowed to 1,035 results for: AAV

1. pAAV-hSyn-hChR2(H134R)-mCherry (AAV8)

   Viral Prep

   #26976-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV-hSyn-hChR2(H134R)-mCherry (#26976). In addition to the viral particles, you will also receive purified pAAV-hSyn-hChR2(H134R)-mCherry plasmid DNA. Synapsin-driven, humanized channelrhodopsin H134R mutant, fused to mCherry for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth

   Promoter

   Syn

   Tags

   mCherry

   Available Since

   Jan. 26, 2021

   Availability

   Academic Institutions and Nonprofits only

2. pAAV-Ef1a-Con/Fon-GCaMP6F (AAV5)

   Viral Prep

   #137122-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV-Ef1a-Con/Fon-GCaMP6F (#137122). In addition to the viral particles, you will also receive purified pAAV-Ef1a-Con/Fon-GCaMP6F plasmid DNA. EF1a-driven, Cre and Flp-dependent expression of GCaMP6f. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth, INTRSECT 2.0 Project

   Article

   Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)

   Promoter

   EF1a

   Available Since

   July 17, 2020

   Availability

   Academic Institutions and Nonprofits only

3. pAAV-hSyn-hChR2(H134R)-mCherry (AAV5)

   Viral Prep

   #26976-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV-hSyn-hChR2(H134R)-mCherry (#26976). In addition to the viral particles, you will also receive purified pAAV-hSyn-hChR2(H134R)-mCherry plasmid DNA. Synapsin-driven, humanized channelrhodopsin H134R mutant, fused to mCherry for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth

   Promoter

   Syn

   Tags

   mCherry

   Available Since

   Oct. 9, 2019

   Availability

   Academic Institutions and Nonprofits only

4. AAV pCAG-FLEX-EGFP-WPRE (AAV5)

   Viral Prep

   #51502-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from AAV pCAG-FLEX-EGFP-WPRE (#51502). In addition to the viral particles, you will also receive purified AAV pCAG-FLEX-EGFP-WPRE plasmid DNA. CAG-driven, Cre dependent EGFP expression control. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Hongkui Zeng

   Article

   Oh et al Nature. 2014 Apr 10;508(7495):207-14. do

   Promoter

   CAG

   Tags

   EGFP (Cre-dependent)

   Available Since

   Oct. 3, 2019

   Availability

   Academic Institutions and Nonprofits only

5. pAAV-CAG-tdTomato (codon diversified) (AAV2)

   Viral Prep

   #59462-AAV2

   Purpose

   Ready-to-use AAV2 particles produced from pAAV-CAG-tdTomato (codon diversified) (#59462). In addition to the viral particles, you will also receive purified pAAV-CAG-tdTomato (codon diversified) plasmid DNA. CAG-driven tdTomato expression control. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Promoter

   CAG

   Tags

   tdTomato (codon diversified)

   Available Since

   April 25, 2019

   Availability

   Academic Institutions and Nonprofits only

6. pAAV-Ef1a-DIO-PPO-Venus (AAV9)

   Viral Prep

   #139505-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-Ef1a-DIO-PPO-Venus (#139505). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO-PPO-Venus plasmid DNA. EF1a-driven, Cre-dependent expression of Venus-tagged parapinopsin for spatiotemporal control of inhibitory GPCR signaling cascades. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Michael Bruchas

   Article

   Copits et al Neuron. 2021 Jun 2;109(11):1791-1809.e11

   Promoter

   EF1a

   Tags

   Venus (Cre-dependent)

   Available Since

   Oct. 28, 2021

   Availability

   Academic Institutions and Nonprofits only

7. pAAV-hSyn-Cre-P2A-dTomato (AAV1)

   Viral Prep

   #107738-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-hSyn-Cre-P2A-dTomato (#107738). In addition to the viral particles, you will also receive purified pAAV-hSyn-Cre-P2A-dTomato plasmid DNA. hSyn-driven expression of Cre and dTomato (physically separate). These AAV preparations are suitable purity for injection into animals.

   Depositor

   Rylan Larsen

   Promoter

   Syn

   Tags

   dTomato (physically separate, not a fusion protein)

   Available Since

   Nov. 9, 2020

   Availability

   Academic Institutions and Nonprofits only

8. pAAV-CaMKIIa-eNpHR 3.0-EYFP (AAV9)

   Viral Prep

   #26971-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-CaMKIIa-eNpHR 3.0-EYFP (#26971). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-eNpHR 3.0-EYFP plasmid DNA. CaMKIIa-driven eNpHR 3.0-EYFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth

   Promoter

   CaMKII

   Tags

   EYFP

   Available Since

   March 30, 2018

   Availability

   Academic Institutions and Nonprofits only

9. pGP-AAV-syn-jGCaMP7s-WPRE (AAV1)

   Viral Prep

   #104487-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pGP-AAV-syn-jGCaMP7s-WPRE (#104487). In addition to the viral particles, you will also receive purified pGP-AAV-syn-jGCaMP7s-WPRE plasmid DNA. Synapsin-driven GCaMP7s calcium sensor. These AAV preparations are suitable purity for injection into animals.

   Depositor

   GENIE Project, Douglas Kim

   Article

   Dana et al Nat Methods. 2019 Jul;16(7):649-657. doi

   Promoter

   Syn

   Available Since

   July 11, 2018

   Availability

   Academic Institutions and Nonprofits only

10. AAV pCAG-FLEX-EGFP-WPRE (AAV2)

    Viral Prep

    #51502-AAV2

    Purpose

    Ready-to-use AAV2 particles produced from AAV pCAG-FLEX-EGFP-WPRE (#51502). In addition to the viral particles, you will also receive purified AAV pCAG-FLEX-EGFP-WPRE plasmid DNA. CAG-driven, Cre dependent EGFP expression control. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Hongkui Zeng

    Article

    Oh et al Nature. 2014 Apr 10;508(7495):207-14. do

    Promoter

    CAG

    Tags

    EGFP (Cre-dependent)

    Available Since

    March 7, 2018

    Availability

    Academic Institutions and Nonprofits only

11. AAV-Syn-H2B-jGCaMP8m-WPRE (AAV9)

    Viral Prep

    #176748-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from AAV-Syn-H2B-jGCaMP8m-WPRE (#176748). In addition to the viral particles, you will also receive purified AAV-Syn-H2B-jGCaMP8m-WPRE plasmid DNA. Syn-driven expression of histone H2B fused to calcium sensor GCaMP8m. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Loren Looger

    Promoter

    Syn

    Available Since

    Feb. 24, 2023

    Availability

    Academic Institutions and Nonprofits only

12. pAAV-Ef1a-Con/Fon-sRGECO (AAV8)

    Viral Prep

    #137126-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pAAV-Ef1a-Con/Fon-sRGECO (#137126). In addition to the viral particles, you will also receive purified pAAV-Ef1a-Con/Fon-sRGECO plasmid DNA. EF1a-driven, Cre and Flp-dependent expression of cytosolic sRGECO calcium sensor. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth, INTRSECT 2.0 Project

    Article

    Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)

    Promoter

    EF1a

    Available Since

    April 5, 2021

    Availability

    Academic Institutions and Nonprofits only

13. pAAV-Ef1a-Coff/Fon-BFP (AAV8)

    Viral Prep

    #137131-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pAAV-Ef1a-Coff/Fon-BFP (#137131). In addition to the viral particles, you will also receive purified pAAV-Ef1a-Coff/Fon-BFP plasmid DNA. EF1a-driven, Flp-dependent expression of BFP (inhibited in presence of Cre). These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth, INTRSECT 2.0 Project

    Article

    Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)

    Promoter

    EF1a

    Tags

    BFP (Flp-dependent)

    Available Since

    April 5, 2021

    Availability

    Academic Institutions and Nonprofits only

14. pAAV-Ef1a-Coff/Fon-GCaMP6M (AAV8)

    Viral Prep

    #137121-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pAAV-Ef1a-Coff/Fon-GCaMP6M (#137121). In addition to the viral particles, you will also receive purified pAAV-Ef1a-Coff/Fon-GCaMP6M plasmid DNA. EF1a-driven expression of GCaMP6m in the presence of Flp recombinase (inhibited in the presence of Cre recombinase). These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth, INTRSECT 2.0 Project

    Article

    Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)

    Promoter

    EF1a

    Available Since

    Nov. 23, 2020

    Availability

    Academic Institutions and Nonprofits only

15. pAAV-hSynapsin1-GCaMP6s-P2A-mRuby3 (AAV9)

    Viral Prep

    #112007-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-hSynapsin1-GCaMP6s-P2A-mRuby3 (#112007). In addition to the viral particles, you will also receive purified pAAV-hSynapsin1-GCaMP6s-P2A-mRuby3 plasmid DNA. hSyn-driven expression of calcium sensor GCaMP6s and bicistronic mRuby3. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Lin Tian

    Article

    Broussard et al Nat Neurosci. 2018 Sep;21(9):1272-1280.

    Promoter

    Syn

    Tags

    mRuby3

    Available Since

    Feb. 14, 2022

    Availability

    Academic Institutions and Nonprofits only

16. pAAV-Ef1a-DIO ChETA-EYFP (AAV5)

    Viral Prep

    #26968-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV-Ef1a-DIO ChETA-EYFP (#26968). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO ChETA-EYFP plasmid DNA. EF1a-driven, Cre-dependent, ChETA fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Article

    Gunaydin et al Nat Neurosci. 2010 Mar;13(3):387-92. doi

    Promoter

    EF1a

    Tags

    EYFP (Cre-dependent)

    Available Since

    Feb. 20, 2018

    Availability

    Academic Institutions and Nonprofits only

17. pAAV-hSynapsin1-GCaMP6s-P2A-mKate2 (AAV9)

    Viral Prep

    #112006-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-hSynapsin1-GCaMP6s-P2A-mKate2 (#112006). In addition to the viral particles, you will also receive purified pAAV-hSynapsin1-GCaMP6s-P2A-mKate2 plasmid DNA. hSyn-driven expression of calcium sensor GCaMP6s and bicistronic mKate2. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Lin Tian

    Article

    Broussard et al Nat Neurosci. 2018 Sep;21(9):1272-1280.

    Promoter

    Syn

    Tags

    mKate2

    Available Since

    Feb. 14, 2022

    Availability

    Academic Institutions and Nonprofits only

18. pAAV-nEF-Con/Fon-iC++-EYFP (AAV8)

    Viral Prep

    #137155-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pAAV-nEF-Con/Fon-iC++-EYFP (#137155). In addition to the viral particles, you will also receive purified pAAV-nEF-Con/Fon-iC++-EYFP plasmid DNA. nEF-driven, Cre and Flp-dependent expression of chloride-conducting channelrhodopsin iC++-EYFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth, INTRSECT 2.0 Project

    Article

    Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)

    Promoter

    nEF

    Tags

    EYFP (Cre and Flp-dependent)

    Available Since

    Dec. 1, 2020

    Availability

    Academic Institutions and Nonprofits only

19. pAAV-EF1a-DIO-JEDI-2P-WPRE (AAV1)

    Viral Prep

    #179460-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-EF1a-DIO-JEDI-2P-WPRE (#179460). In addition to the viral particles, you will also receive purified pAAV-EF1a-DIO-JEDI-2P-WPRE plasmid DNA. EF1a-driven, Cre-dependent expression of voltage indicator JEDI-2P. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Francois St-Pierre

    Article

    Liu et al Cell. 2022 Aug 16. pii: S0092-8674(22)00

    Promoter

    EF1a

    Tags

    cEGFP (Cre-dependent)

    Available Since

    Aug. 22, 2022

    Availability

    Academic Institutions and Nonprofits only

20. pAAV-Syn-ChR2(H134R)-GFP (AAV8)

    Viral Prep

    #58880-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pAAV-Syn-ChR2(H134R)-GFP (#58880). In addition to the viral particles, you will also receive purified pAAV-Syn-ChR2(H134R)-GFP plasmid DNA. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Edward Boyden

    Article

    Boyden et al Nat Neurosci. 2005 Sep . 8(9):1263-8.

    Promoter

    Syn

    Tags

    GFP

    Available Since

    Oct. 13, 2017

    Availability

    Academic Institutions and Nonprofits only